Prognostic Factors in Breast Cancer
作者： Jan G. M. Klijn , John A. Foekens
DOI: 10.1007/978-3-642-75948-2_4
关键词:
摘要: New directions in research regarding adjuvant treatment of patients with early breast cancer concerns (potential) new modalities and better selection high- low-risk patients. In the current discussion on application systemic therapy primary cancer, identification is a major issue [1]. Several classical (Table 1) second generation prognostic factors (proliferation rate, DNA ploidy, oncogenes, growth factor receptors, some glycoproteins) are used for making therapeutic decisions [2]. At present, more than 60 parameters have been reported can be classified into 4 main groups: patient characteristics, blood parameters, tumour characteristics response to 2).
springer.com
sci-hub.st 参考文章(84)
Iqbal Unnisa Ali, Rosette Lidereau, Robert Callahan, Heterogeneity of genetic alterations in primary human breast tumors Cancer treatment and research. ,vol. 40, pp. 25- 48 ,(1988) , 10.1007/978-1-4613-1733-3_2
Robert B. Dickson, Marc E. Lippman, Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer treatment and research. ,vol. 40, pp. 119- 165 ,(1988) , 10.1007/978-1-4613-1733-3_6
Adrian L. Harris, Stewart Nicholson, Epidermal growth factor receptors in human breast cancer. Cancer treatment and research. ,vol. 40, pp. 93- 118 ,(1988) , 10.1007/978-1-4613-1733-3_5
Hiroo Imura, Norio Waseda, Yuzuru Kato, Masahiko Kurata, Prognostic value of estrogen and prolactin receptor analysis in human breast cancer. Japanese Journal of Cancer Research. ,vol. 76, pp. 517- 523 ,(1985) , 10.20772/CANCERSCI1985.76.6_517
G Sliutz, R Zeillinger, E Kubista, K Czerwenka, R Jakesz, G Reiner, J Huber, F Kury, W Knogler, C Zielinski, HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene. ,vol. 4, pp. 109- 114 ,(1989)
Fredrika Pekonen, Tuulikki Mäkinen, Seppo Partanen, Eeva-Marja Rutanen, Receptors for Epidermal Growth Factor and Insulin-like Growth Factor I and Their Relation to Steroid Receptors in Human Breast Cancer Cancer Research. ,vol. 48, pp. 1343- 1347 ,(1988)
W J Gullick, P Kelly, Sainsbury, C Wright, A L Harris, B Angus, J Cairns, S Nicholson, C H Horne, Expression of c-erbB-2 Oncoprotein: A Prognostic Indicator in Human Breast Cancer Cancer Research. ,vol. 49, pp. 2087- 2090 ,(1989)
William Godolphin, Lydia L. M. Shek, Model for Breast Cancer Survival: Relative Prognostic Roles of Axillary Nodal Status, TNM Stage, Estrogen Receptor Concentration, and Tumor Necrosis Cancer Research. ,vol. 48, pp. 5565- 5569 ,(1988)
H Portengen, H A Peters, J Alexieva-Figusch, H L Krijnen, W L van Putten, J A Foekens, J G Klijn, Prognostic Value of Estrogen and Progesterone Receptors Measured by Enzyme Immunoassays in Human Breast Tumor Cytosols Cancer Research. ,vol. 49, pp. 5823- 5828 ,(1989)
J.-C. Reubi, H. Portengen, A. M. A. C. Trapman, J. Alexieva-Figusch, W. L. J. Van Putten, J. A. Foekens, J. G. M. Klijn, Prognostic Value of Receptors for Insulin-like Growth Factor 1, Somatostatin, and Epidermal Growth Factor in Human Breast Cancer Cancer Research. ,vol. 49, pp. 7002- 7009 ,(1989)